Moreover, 67LR also acts as a cancer specific death receptor through activation of the cGMP/ASM axis [25,26,27] and inhibits the growth of melanoma through cytoskeletal rearrangement [19,44]. This evidence concerns the gene SMPD1 and melanoma.